View Full PDF
Those with diets high in antioxidant foods literally halve their risk for dementia compared to those with low intakes, according to a study last year of 2,716 people aged over 60
Evidence boundary No human clinical trial has tested cagrilintide + tirzepatide together
Figure 1: Changes in body weight from baseline to the end of treatment at week 26 associated with the trial product estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Most excluded studies focused on specific dermatological conditions (acne, psoriasis, radiotherapy-induced dermatitis) rather than addressing general skin health and age-related changes